GeminIQ Website Logo

Viewing HCAT free

Subscribe for full history, 90+ metrics, screener, watchlist...

Health Catalyst, Inc.

HCAT

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
616051405134225032820220110695
Short Term Investments
4349455147014259106126211253
Accounts Receivable Net Current
425959606864575255546046
Prepaid Expense And Other Assets Current
121414141517161913151515
Assets Current
248182169165181423466457376397393408
Property Plant And Equipment Net
333534333332292826252626
Intangible Assets Net Excluding Goodwill
5669789098106867667667372
Operating Lease Right Of Use Asset
6677121212112121415
Goodwill
11113209286286313260234206191191186
Other Assets Noncurrent
466756665455
Assets
359412503587616892859813692695702713
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
8129599111411676
Contract With Customer Liability Current
437056596771535256645653
Operating Lease Liability Current
444444433333
Business Combination Contingent Consideration Liab…
--------1---
Senior Notes
--------229---
Long Term Debt Current
22222232231230--0-
Liabilities Current
92108908899340326324318928984
Long Term Debt Noncurrent
1521521521521511511511150228228228
Contract With Customer Liability Noncurrent
000000000000
Operating Lease Liability Noncurrent
131314151616161617171818
Business Combination Contingent Consideration Liab…
0000270-----
Other Liabilities Noncurrent
111000030000
Liabilities
258274257255269515494458335338335331
Stockholders Equity
Preferred Stock Value
000000000000
Common Stocks Including Additional Paid In Capital
1,6161,6131,6091,6041,5971,5871,5531,5211,5081,4951,4841,469
Retained Earnings Accumulated Deficit
-1,516-1,476-1,365-1,274-1,251-1,210-1,187-1,166-1,151-1,138-1,117-1,087
Accumulated Other Comprehensive Income Loss Net Of…
112220-1-0-0-00-0
Stockholders Equity
101138246332348377365355357357367382
Liabilities And Stockholders Equity
359412503587616892859813692695702713
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
252525252525252525252525
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
500500500500500500500500500500500500
Common Stock Shares Issued
757472717069646160595857
Shares Outstanding
757472717069646160595857

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202639.86%50.72%51.45%---------
2025-7.99%-7.75%-6.05%19.79%-1.06%14.49%-8.77%-20.00%-24.56%-34.64%-18.99%-22.91%
20243.43%-0.31%20.59%-4.77%10.07%1.46%-0.34%-20.09%-34.88%-10.73%-22.27%-17.81%
2023----5.94%-18.78%-44.94%5.11%27.90%42.27%-7.67%-28.10%-24.32%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.70
1.69
1.89
1.88
1.83
1.24
1.43
1.41
1.18
4.31
4.42
4.85
Quick Ratio
2.58
1.56
1.73
1.73
1.68
1.20
1.38
1.36
1.14
4.14
4.25
4.67
Working Capital
156.47M
74.70M
79.73M
77.46M
81.75M
83.16M
139.80M
133.63M
58.04M
304.93M
304.36M
324.20M
Leverage & Debt
Debt to Equity
2.56
1.98
1.05
0.77
0.77
1.37
1.35
1.29
0.94
0.95
0.91
0.86
Interest Coverage TTM
-14.40
-14.38
-9.81
-6.41
-7.88
-6.87
-7.97
-6.69
-6.95
-10.03
-13.94
-50.19
Debt Ratio
0.72
0.66
0.51
0.43
0.44
0.58
0.57
0.56
0.48
0.49
0.48
0.46
Efficiency & Turnover
Asset Turnover TTM
0.60
0.46
0.46
0.45
0.48
0.39
0.39
0.40
0.42
0.41
0.41
0.39
Days Sales Outstanding TTM
68.87
74.33
68.22
64.53
71.17
69.14
69.93
59.05
65.37
71.17
66.76
60.18
Receivables Turnover TTM
5.30
4.91
5.35
5.66
5.13
5.28
5.22
6.18
5.58
5.13
5.47
6.07
Per Share Metrics
Diluted EPS TTM
-3.58
-3.65
-2.55
-1.53
-1.44
-1.06
-1.15
-1.31
-1.46
-1.80
-2.09
-2.18
Free Cash Flow Per Share TTM
0.11
0.23
-0.03
-0.22
-0.13
0.04
0.22
-0.04
-0.08
-0.31
-0.61
-0.53
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
50.48%
49.89%
48.75%
46.50%
45.31%
45.24%
45.92%
45.22%
44.92%
44.64%
44.55%
45.65%
Operating Profit Margin TTM
-84.36%
-81.71%
-51.70%
-29.19%
-27.98%
-21.58%
-22.77%
-28.17%
-32.05%
-38.68%
-42.88%
-45.12%
Net Profit Margin TTM
-90.61%
-87.69%
-57.20%
-34.05%
-31.67%
-23.34%
-22.67%
-26.20%
-28.87%
-35.56%
-39.92%
-42.62%
Growth Metrics
Net Revenue Growth (1Y)
-7.54%
-2.83%
1.48%
4.64%
5.55%
4.88%
3.60%
4.15%
5.23%
5.24%
7.13%
6.71%
Net Income Growth (1Y)
164.50%
265.08%
156.07%
35.99%
15.82%
-31.16%
-41.17%
-35.98%
-41.32%
-28.75%
-14.01%
-17.92%
EPS Growth (1Y)
149.00%
244.76%
120.49%
16.79%
-1.35%
-41.16%
-44.85%
-39.93%
-44.61%
-32.53%
-18.12%
-21.41%
Valuation Metrics
P/E TTM
-0.56
-0.35
-0.94
-1.86
-2.62
-4.27
-6.12
-6.22
-4.38
-4.18
-4.42
-4.64
P/B TTM
1.46
0.67
0.68
0.60
0.76
0.82
1.17
1.39
1.06
1.24
1.42
1.50
P/S TTM
0.50
0.30
0.54
0.63
0.83
1.00
1.39
1.63
1.27
1.49
1.77
1.98
Market Cap
147.18M
92.19M
167.05M
200.57M
262.49M
310.54M
425.51M
491.99M
378.95M
441.19M
522.43M
573.91M
Enterprise Value
240.07M
185.69M
269.49M
313.41M
364.80M
351.43M
558.22M
508.69M
405.85M
468.24M
644.19M
706.60M
Calculated Values
Free Cash Flow TTM
8.46M
16.53M
-2.04M
-15.23M
-9.00M
2.50M
12.94M
-2.41M
-4.95M
-18.25M
-34.32M
-30.26M
Net Debt
92.89M
93.50M
102.44M
112.83M
102.32M
40.89M
132.72M
16.71M
26.90M
27.04M
121.76M
132.68M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-12-05Sale
Owner: Landry, Benjamin
Title: General Counsel
Shares: 27,425
Price/Share: $2.64
Value: $72,402.00
Shares Owned: 100,000
Relationship: Officer
Ownership: Direct
2025-12-04Sale
Owner: Larson-Green, Julie
Title: -
Shares: 47,997
Price/Share: $2.67
Value: $128,151.99
Shares Owned: 73,573
Relationship: Director
Ownership: Direct
2025-09-05Sale
Owner: Landry, Benjamin
Title: General Counsel
Shares: 6,175
Price/Share: $3.35
Value: $20,686.25
Shares Owned: 141,812
Relationship: Officer
Ownership: Direct
2025-06-05Sale
Owner: Landry, Benjamin
Title: General Counsel
Shares: 6,057
Price/Share: $3.94
Value: $23,864.58
Shares Owned: 151,125
Relationship: Officer
Ownership: Direct
2025-05-05Sale
Owner: Lesueur, Daniel
Title: Chief Operating Officer
Shares: 5,209
Price/Share: $4.10
Value: $21,356.90
Shares Owned: 205,832
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
75.18%
Inst. Shares: 54,575,565
Shares Outstanding: 72,593,210
2025-12-31
77.19%
Inst. Shares: 53,954,796
Shares Outstanding: 69,896,134
2025-09-30
75.06%
Inst. Shares: 52,827,603
Shares Outstanding: 70,376,760
2025-06-30
75.29%
Inst. Shares: 52,422,122
Shares Outstanding: 69,625,540
2025-03-31
72.44%
Inst. Shares: 49,659,507
Shares Outstanding: 68,552,084

Health Catalyst, Inc. (HCAT) — SEC Financial Statements & Analysis

Health Catalyst, Inc. (HCAT) is a services-computer programming, data processing, etc. company, incorporated in DE. Health Catalyst, Inc. trades on Nasdaq as: HCAT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Health Catalyst, Inc. reported a -7.54% year-over-year revenue growth, a Gross Profit Margin of 50.48% (TTM), a Debt-to-Equity ratio of 2.56x, a Price-to-Sales (P/S) ratio of 0.50x (TTM), a Price-to-Book (P/B) ratio of 1.46x (TTM), at a market cap of $147.18M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-7.54%
Gross Profit Margin TTM
50.48%
Debt To Equity
2.56x
P/S TTM
0.50x
P/B TTM
1.46x
Market Cap
$147.18M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Health Catalyst, Inc. in?

Health Catalyst, Inc. (HCAT) operates in the Services-Computer Programming, Data Processing, Etc. industry.

What is HCAT's market cap?

Health Catalyst, Inc. (HCAT) has a market capitalization of $147.18M as of 2026-06-30.

What exchange does HCAT trade on?

Health Catalyst, Inc. (HCAT) trades on the Nasdaq.

Where is Health Catalyst, Inc. incorporated?

Health Catalyst, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.